News

Harvard Medical School Cancels Student Groups’ Pro-Palestine Vigil

News

Former FTC Chair Lina Khan Urges Democrats to Rethink Federal Agency Function at IOP Forum

News

Cyanobacteria Advisory Expected To Lift Before Head of the Charles Regatta

News

After QuOffice’s Closure, Its Staff Are No Longer Confidential Resources for Students Reporting Sexual Misconduct

News

Harvard Still On Track To Reach Fossil Fuel-Neutral Status by 2026, Sustainability Report Finds

Saccharin Panel

News Shorts

By John C. Scheffel

Brian H. MacMahon, Wolcott Professor of Epidemiology in the Faculty of Public Health, is serving on a panel which will evaluate the Food and Drug Administration's proposed saccharin ban for a Congressional committee.

The panel, chosen by the congressional Office of Technology Assessment (OTA) met for the first time last weekend. It will report to the Senate Subcommittee on Health on the risks and benefits of saccharin consumption, and the availability of other sweeteners in a report due June 1.

The OTA chose MacMahon because "he is a first rate scientist and the best epidemiologist the OTA could find," a spokesman for the OTA said yesterday.

MacMahon said the panel reached general agreement about the contents of its report at the weekend meeting and its staff has begun to write a final draft of its conclusions.

He added that the contents of the report are confidential until the final version is produced and declined comment on his personal opinions about saccharin's risks.

Senators Edward M. Kennedy '54(D.-Mass.) and Richard S. Schweiker (R-Pa.), requested the OTA appoint the panel to study saccharin.

A spokesman in Kennedy's office said yesterday the members of the panel would probably be called to testify before the Senate health subcommittee during hearings on June 6 and 7.

Want to keep up with breaking news? Subscribe to our email newsletter.

Tags